Literature DB >> 29286433

Methodology for Sputum Induction and Laboratory Processing.

Julien Guiot1, Sophie Demarche2, Monique Henket3, Virginie Paulus3, Sophie Graff3, Florence Schleich3, Jean-Louis Corhay3, Renaud Louis3, Catherine Moermans3.   

Abstract

The technique of sputum induction and processing is a recognized non-invasive method allowing the collection and analysis of cells from the airways, which is interesting in various respiratory diseases like asthma, chronic obstructive pulmonary disease (COPD), chronic cough, or idiopathic pulmonary fibrosis. This technique is well tolerated, safe and non-invasive, but is currently limited to research services and specialized centers in clinical practice because it is technically demanding, time-consuming, and requires trained staff. The success rate of sputum induction and analysis is about 80%. Here, we describe the induction and laboratory processing of sputum samples. Sputum is induced by inhalation of hypertonic or isotonic saline with salbutamol. For the processing, we use the whole sputum technique. Dithiothreitol (DTT) is used to allow mucolysis of sputum samples. The primary aim of sputum processing is to obtain a differential cell count to study the cell types present in the airway lumen. Additional analyses may also be performed on sputum supernatant and sputum cells, which may allow further investigation into inflammatory processes and immune mechanisms. Examples include studying mediators in sputum supernatant and performing a large spectrum of analysis on sputum cells such as flow cytometry, genomics, or proteomics. Finally, representative results of sputum analysis in healthy controls, asthmatics, and COPD patients are presented.

Entities:  

Mesh:

Year:  2017        PMID: 29286433      PMCID: PMC5755606          DOI: 10.3791/56612

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  37 in total

1.  Nebulised salbutamol administered during sputum induction improves bronchoprotection in patients with asthma.

Authors:  M Delvaux; M Henket; L Lau; P Kange; P Bartsch; R Djukanovic; R Louis
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

Review 2.  Safety of sputum induction.

Authors:  E Pizzichini; M M M Pizzichini; R Leigh; R Djukanović; P J Sterk
Journal:  Eur Respir J Suppl       Date:  2002-09

Review 3.  Standardised methodology of sputum induction and processing. Future directions.

Authors:  A M Vignola; S I Rennar; F E Hargreave; J V Fah; M R Bonsignore; R Djukanović; P J Sterk
Journal:  Eur Respir J Suppl       Date:  2002-09

Review 4.  Clinical applications of assessment of airway inflammation using induced sputum.

Authors:  I D Pavord; P J Sterk; F E Hargreave; J C Kips; M D Inman; R Louis; M M M Pizzichini; E H Bel; I Pin; D C Grootendorst; K Parameswaran; R Djukanović
Journal:  Eur Respir J Suppl       Date:  2002-09

5.  Local and systemic cellular inflammation and cytokine release in chronic obstructive pulmonary disease.

Authors:  C Moermans; V Heinen; M Nguyen; M Henket; J Sele; M Manise; J L Corhay; R Louis
Journal:  Cytokine       Date:  2011-08-30       Impact factor: 3.861

6.  Changes in sputum composition between two inductions performed on consecutive days.

Authors:  O Holz; K Richter; R A Jörres; P Speckin; M Mücke; H Magnussen
Journal:  Thorax       Date:  1998-02       Impact factor: 9.139

7.  Asthma inflammatory phenotypes show differential microRNA expression in sputum.

Authors:  Tania Maes; Francisco Avila Cobos; Florence Schleich; Valentina Sorbello; Monique Henket; Katleen De Preter; Ken R Bracke; Griet Conickx; Claire Mesnil; Jo Vandesompele; Lies Lahousse; Fabrice Bureau; Pieter Mestdagh; Guy F Joos; Fabio L M Ricciardolo; Guy G Brusselle; Renaud Louis
Journal:  J Allergy Clin Immunol       Date:  2016-05       Impact factor: 10.793

8.  The effect of processing on inflammatory markers in induced sputum.

Authors:  R Louis; J Shute; K Goldring; B Perks; L C Lau; M Radermecker; R Djukanovic
Journal:  Eur Respir J       Date:  1999-03       Impact factor: 16.671

9.  Asthma Control and Sputum Eosinophils: A Longitudinal Study in Daily Practice.

Authors:  Sophie F Demarche; Florence N Schleich; Virginie A Paulus; Monique A Henket; Thierry J Van Hees; Renaud E Louis
Journal:  J Allergy Clin Immunol Pract       Date:  2017-04-25

10.  Sputum induction for diagnosis of Pneumocystis carinii pneumonia.

Authors:  T R Leigh; P Parsons; C Hume; O A Husain; B Gazzard; J V Collins
Journal:  Lancet       Date:  1989-07-22       Impact factor: 79.321

View more
  15 in total

1.  Predictors of High Sputum Eosinophils in Chronic Obstructive Pulmonary Disease.

Authors:  Xiang Wen; Jieqi Peng; Youlan Zheng; Jiaxing Liu; Heshen Tian; Fan Wu; Zihui Wang; Huajing Yang; Zhishan Deng; Shan Xiao; Peiyu Huang; Jianwu Xu; Cuiqiong Dai; Ningning Zhao; Lifei Lu; Jianwei Dai; Bing Li; Pixin Ran; Yumin Zhou
Journal:  Chronic Obstr Pulm Dis       Date:  2022-07-29

Review 2.  Diagnostic Accuracy of Liquid Biomarkers in Airway Diseases: Toward Point-of-Care Applications.

Authors:  Vivianne Landry; Patrick Coburn; Karen Kost; Xinyu Liu; Nicole Y K Li-Jessen
Journal:  Front Med (Lausanne)       Date:  2022-06-06

3.  Association Between FeNO, Total Blood IgE, Peripheral Blood Eosinophil and Inflammatory Cytokines in Partly Controlled Asthma.

Authors:  Ahmed Badar; Ayad Mohammed Salem; Abdullah Omar Bamosa; Hatem Othman Qutub; Rakesh Kumar Gupta; Intisar Ahmad Siddiqui
Journal:  J Asthma Allergy       Date:  2020-10-29

Review 4.  Assessing Response to Therapy for Nontuberculous Mycobacterial Lung Disease: Quo Vadis?

Authors:  Christopher Vinnard; Alyssa Mezochow; Hannah Oakland; Ross Klingsberg; John Hansen-Flaschen; Keith Hamilton
Journal:  Front Microbiol       Date:  2018-11-20       Impact factor: 5.640

Review 5.  Review of Drug Development Guidance to Treat Chronic Obstructive Pulmonary Disease: US and EU Perspectives.

Authors:  Aernout van Haarst; Lorcan McGarvey; Sabina Paglialunga
Journal:  Clin Pharmacol Ther       Date:  2019-07-23       Impact factor: 6.875

Review 6.  Exosomal miRNAs in Lung Diseases: From Biologic Function to Therapeutic Targets.

Authors:  Julien Guiot; Ingrid Struman; Edouard Louis; Renaud Louis; Michel Malaise; Makon-Sébastien Njock
Journal:  J Clin Med       Date:  2019-08-29       Impact factor: 4.241

7.  Relationship Between Proteinase with a Disintegrin and a Metalloproteinase Domain-9 (ADAM9), Inflammation, Airway Remodeling, and Emphysema in COPD Patients.

Authors:  Liwei Cui; Haijun Li; Mengshuang Xie; Xia Xu; Yingmei Zhang; Wei Wang; Shuang Dou; Wei Xiao
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-12-14

8.  Macrophage-derived exosomes attenuate fibrosis in airway epithelial cells through delivery of antifibrotic miR-142-3p.

Authors:  Ingrid Struman; Makon-Sébastien Njock; Julien Guiot; Maureen Cambier; Amandine Boeckx; Monique Henket; Olivier Nivelles; Fanny Gester; Edouard Louis; Michel Malaise; Franck Dequiedt; Renaud Louis
Journal:  Thorax       Date:  2020-08-05       Impact factor: 9.139

9.  Chronic oral corticosteroids use and persistent eosinophilia in severe asthmatics from the Belgian severe asthma registry.

Authors:  S Graff; S Vanwynsberghe; G Brusselle; S Hanon; C Sohy; L J Dupont; R Peche; A Michils; C Pilette; G Joos; R E Louis; F N Schleich
Journal:  Respir Res       Date:  2020-08-12

10.  Anal swab as a potentially optimal specimen for SARS-CoV-2 detection to evaluate hospital discharge of COVID-19 patients.

Authors:  Mei Sun; Dong Guo; Jing Zhang; Jian Zhang; Hai-Feng Teng; Jun Xia; Peng Liu; Quan-Xu Ge; Ming-Yi Wang
Journal:  Future Microbiol       Date:  2020-08-14       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.